Amalgamated Bank’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,351
| Closed | -$2K | – | 3076 |
|
|
2025
Q1 | $2K | Hold |
4,351
| – | – | ﹤0.01% | 2850 |
|
|
2024
Q4 | $2K | Hold |
4,351
| – | – | ﹤0.01% | 2908 |
|
|
2024
Q3 | $4K | Hold |
4,351
| – | – | ﹤0.01% | 2823 |
|
|
2024
Q2 | $4K | Hold |
4,351
| – | – | ﹤0.01% | 2858 |
|
|
2024
Q1 | $6K | Sell |
4,351
-13,919
| -76% | -$19.2K | ﹤0.01% | 2650 |
|
|
2023
Q4 | $20K | Sell |
18,270
-1,295
| -7% | -$1.42K | ﹤0.01% | 2646 |
|
|
2023
Q3 | $23K | Hold |
19,565
| – | – | ﹤0.01% | 2585 |
|
|
2023
Q2 | $28K | Buy |
+19,565
| New | +$28K | ﹤0.01% | 2572 |
|
|
2022
Q2 | – | Sell |
-15,165
| Closed | -$23K | – | 3129 |
|
|
2022
Q1 | $23K | Sell |
15,165
-1,141
| -7% | -$1.73K | ﹤0.01% | 2758 |
|
|
2021
Q4 | $40K | Sell |
16,306
-237
| -1% | -$581 | ﹤0.01% | 2117 |
|
|
2021
Q3 | $42K | Sell |
16,543
-524
| -3% | -$1.33K | ﹤0.01% | 2140 |
|
|
2021
Q2 | $49K | Buy |
+17,067
| New | +$49K | ﹤0.01% | 2165 |
|
|
2020
Q2 | – | Sell |
-15,254
| Closed | -$13K | – | 1573 |
|
|
2020
Q1 | $13K | Sell |
15,254
-1,197
| -7% | -$1.02K | ﹤0.01% | 1641 |
|
|
2019
Q4 | $15K | Buy |
16,451
+1,903
| +13% | +$1.74K | ﹤0.01% | 1834 |
|
|
2019
Q3 | $14K | Sell |
14,548
-180
| -1% | -$173 | ﹤0.01% | 1763 |
|
|
2019
Q2 | $16K | Buy |
14,728
+1,859
| +14% | +$2.02K | ﹤0.01% | 1794 |
|
|
2019
Q1 | $17K | Buy |
12,869
+597
| +5% | +$789 | ﹤0.01% | 1685 |
|
|
2018
Q4 | $11K | Buy |
12,272
+833
| +7% | +$747 | ﹤0.01% | 1624 |
|
|
2018
Q3 | $24K | Sell |
11,439
-2,834
| -20% | -$5.95K | ﹤0.01% | 1433 |
|
|
2018
Q2 | $26K | Buy |
14,273
+1,535
| +12% | +$2.8K | ﹤0.01% | 1731 |
|
|
2018
Q1 | $30K | Sell |
12,738
-280
| -2% | -$659 | ﹤0.01% | 1597 |
|
|
2017
Q4 | $24K | Buy |
+13,018
| New | +$24K | ﹤0.01% | 1642 |
|